Drugs / Trichuris Ova Suis
Trichuris Ova Suis
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01734941 Comparator | Apr 2014 → May 2015 | autism spectrum disorder | Hadassah Medical Organization | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trichuris Ova Suis | “including Trichuris Ova Suis (TSO), a helminth porcine whipworm” NCT01734941 ↗ |
| Known as | Trichuris suis ova | “This is a randomized, three-arm double-blind, placebo-controlled, single-center study to evaluate the effects of oral administration of Trichuris suis ova (as compared to...” NCT01734941 ↗ |
| Known as | TSO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01734941 ↗ |
| Modality | Other / unclassified | “a helminth porcine whipworm” NCT01734941 ↗ |